title: Refractory bullous pemphigoid with fatal outcome in a young patient.
authors.affiliation: Department of Dermatology and Venereology and Pathology, Hospital de São João EPE, Porto, Portugal. mjmc@live.com.pt
authors.forename: Maria João
authors.initials: MJ
authors.lastname: Cruz
authors.forename: Paulo
authors.initials: P
authors.lastname: Santos
authors.forename: Paulo
authors.initials: P
authors.lastname: Morais
authors.forename: Filomena
authors.initials: F
authors.lastname: Barreto
authors.forename: Filomena
authors.initials: F
authors.lastname: Azevedo
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use; D000069283:Rituximab
chemical_list: D000893:Anti-Inflammatory Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine